Literature DB >> 7685064

Localization of GM1 and GD1b antigens in the human peripheral nervous system.

S Kusunoki1, A Chiba, T Tai, I Kanazawa.   

Abstract

Serum antibodies against ganglioside GM1 and/or GD1b are frequently detected in autoimmune neuropathies such as multifocal motor neuropathy, IgM paraproteinemic neuropathy and Guillain-Barré syndrome. Some of them bind to GM1 or GD1b monospecifically but others cross-react with both of the antigens. In order to investigate the respective localizations of GM1 and GD1b antigens in the human peripheral nervous system, an immunohistochemical study was performed using two mouse monoclonal antibodies, each monospecific to GM1 and GD1b. GGR12, monospecific to GD1b, bound to neurons in dorsal root ganglia and sympathetic ganglia, and some parts of the peripheral myelin, mainly the paranodal areas. However GMB16, monospecific to GM1, did not bind to either neurons or myelin. GD1b antigen present on neurons and paranodal myelin in the peripheral nervous system can be a target antigen of serum antibodies in autoimmune neuropathies. Further effort should be made to reveal the localization of GM1 antigen in the human peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685064     DOI: 10.1002/mus.880160710

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  A case of Guillain-Barré syndrome associated with cerebellar ataxia and positive serum anti-GD1b IgG antibody.

Authors:  Hideki Sugimoto; Nobuo Wakata; Masahiko Kishi; Toshiki Fujioka; Teruyuki Kurihara; Yukiko Irie; Toyokazu Saito
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

2.  Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.

Authors:  Simon N Fewou; Angie Rupp; Lauren E Nickolay; Kathryn Carrick; Kay N Greenshields; John Pediani; Jaap J Plomp; Hugh J Willison
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

Review 3.  Gangliosides and glycosphingolipids of peripheral nervous system myelins--a minireview.

Authors:  K Ogawa-Goto; T Abe
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Antibodies to Glycolipids in Guillain-Barré Syndrome, Miller Fisher Syndrome and Related Autoimmune Neurological Diseases.

Authors:  Susumu Kusunoki
Journal:  Adv Neurobiol       Date:  2023

Review 5.  Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.

Authors:  Andreas J Steck; Adam Czaplinski; Susanne Renaud
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 6.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

7.  Diffuse large B-cell lymphoma involving peripheral nervous system with IgM antibodies against GM1 and GD1b: A case report.

Authors:  Zhaocai Jiang; Weina Ju; Shen Luo; Yu Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 8.  The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  Front Aging Neurosci       Date:  2021-01-13       Impact factor: 5.750

9.  CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy.

Authors:  Takahiro Furukawa; Naoko Matsui; Koji Fujita; Hiroyuki Nodera; Fumitaka Shimizu; Katsuichi Miyamoto; Yukitoshi Takahashi; Takashi Kanda; Susumu Kusunoki; Yuishin Izumi; Ryuji Kaji
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.